Your browser doesn't support javascript.
loading
A randomised phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in advanced squamous cell lung carcinoma (C-TONG1002).
Wang, Zhen; Huang, Cheng; Yang, Jin-Ji; Song, Yong; Cheng, Ying; Chen, Gong-Yan; Yan, Hong-Hong; Ben, Xiao-Song; Wang, Bin-Chao; Xu, Chong-Rui; Jiang, Ben-Yuan; Zhou, Qing; Chen, Hua-Jun; Wu, Yi-Long.
Afiliação
  • Wang Z; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, 106 Zhongshan 2nd Road, Guangzhou 510080, People's Republic of China. Electronic address: hunterol@hotmail.com.
  • Huang C; Fujian Province Cancer Hospital, 91 Fu Ma Road, Fuzhou, China. Electronic address: cheng671@sina.com.
  • Yang JJ; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, 106 Zhongshan 2nd Road, Guangzhou 510080, People's Republic of China. Electronic address: yangjinji2003@163.com.
  • Song Y; Nanjing General Hospital, 305 Zhong Shan Dong Road, Nanjing, China. Electronic address: yong_song6310@yahoo.com.
  • Cheng Y; Jilin Province Cancer Hospital, 1018 Hu Guang Road, Changchun, China. Electronic address: jl.cheng@163.com.
  • Chen GY; Heilongjiang Province Cancer Hospital, 150 Ha Ping Road, Harbin, China. Electronic address: chengongyan@163.com.
  • Yan HH; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, 106 Zhongshan 2nd Road, Guangzhou 510080, People's Republic of China. Electronic address: yanhonghong385@126.com.
  • Ben XS; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, 106 Zhongshan 2nd Road, Guangzhou 510080, People's Republic of China. Electronic address: benxs@163.com.
  • Wang BC; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, 106 Zhongshan 2nd Road, Guangzhou 510080, People's Republic of China. Electronic address: wbc_gz@hotmail.com.
  • Xu CR; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, 106 Zhongshan 2nd Road, Guangzhou 510080, People's Republic of China. Electronic address: xucr@hotmail.com.
  • Jiang BY; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, 106 Zhongshan 2nd Road, Guangzhou 510080, People's Republic of China. Electronic address: jiangben1000@126.com.
  • Zhou Q; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, 106 Zhongshan 2nd Road, Guangzhou 510080, People's Republic of China. Electronic address: gzzhouqing@126.com.
  • Chen HJ; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, 106 Zhongshan 2nd Road, Guangzhou 510080, People's Republic of China. Electronic address: chjdoctor@163.com.
  • Wu YL; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, 106 Zhongshan 2nd Road, Guangzhou 510080, People's Republic of China. Electronic address: syylwu@live.cn.
Eur J Cancer ; 109: 183-191, 2019 03.
Article em En | MEDLINE | ID: mdl-30739019

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article